Mutations in the BRAF gene occur in ~40–85% of melanoma cases, with the lowest frequency in primary melanomas, increased in metastatic sites, and the highest in recurrent melanomas, while NRAS mutation occurs in ~25% [19,20]. The gene discussed is NRAS; the disease is melanoma.